PAR 5.10% 23.3¢ paradigm biopharmaceuticals limited..

PR has let the long term holders down due to greed. This high...

  1. 85 Posts.
    lightbulb Created with Sketch. 29
    PR has let the long term holders down due to greed. This high level greed has gotten in the way of good decision making, otherwise PR would have raised far more capital in the last cap raise, Marco wouldn't have been given the door after saying something like mission accomplished which seems to me a deal come in that PR didn't like (that possible deal might look pretty good now). That as soon as the cash was low talk of DMOAD won't get in the way of pain and function approvals and non dilutive deals was exactly what share holders wanted to hear are the focus while in the background he just spend $22.5m in a quarter and getting ready for a cap raise. He runs the company like it's private and his not aligned with share holders having such a high salary to offset cap raise after cap raise. I really hope that supply agreement is water tight as the drug is a blockbuster along with the excellent safety profile and sports stars on channel 7. This gives me confidence that any leadership in this space could come in and get this thing to market with aligned share holder interest over our sub Par greedy CEO.

    Optimus
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.3¢
Change
-0.013(5.10%)
Mkt cap ! $83.95M
Open High Low Value Volume
26.0¢ 26.0¢ 23.0¢ $170.1K 698.2K

Buyers (Bids)

No. Vol. Price($)
9 141633 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 37554 7
View Market Depth
Last trade - 14.17pm 06/05/2024 (20 minute delay) ?
Last
24.0¢
  Change
-0.013 ( 4.00 %)
Open High Low Volume
25.0¢ 26.0¢ 23.0¢ 376663
Last updated 14.26pm 06/05/2024 ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.